Recovery of ischemic stroke from 5th to 21st post stroke day

To evaluate the effect of Intracarotid Sodium Nitroprusside (IASNP) with double dose platelet rich plasma in humans of Sub acute ischemic stroke (from 5th to 21st day of POST STROKE DAY? in 75 cases - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093437

Enrollment

Registered

2025-08-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G968- Other specified disorders of central nervous system

Interventions

Intervention1: SODIUM NITROPRUSSIDE WITH DOUBLE DOSE PRP: To evaluate the effect of Intracarotid Sodium Nitroprusside (IASNP) with double dose platelet rich plasma in humans of Sub acute ischemic stro

Eligibility

Inclusion criteria

Inclusion criteria: ISCHEMIC STROKE FROM 5TH TO 21ST POST STROKE DAY NEUROLOGICAL DEFICIET CASES ALTENS INDICATING LESS THAN 7 mAmp MRI DWI positive hyperintense CASES

Exclusion criteria

Exclusion criteria: HEMORAGIC CASES SEVERELY ILL WITH LOW GCS CASES BELOW E2V2M5

Design outcomes

Primary

Measure	Time frame
IMPROVEMENT IN NEUROLOGICAL DEFICIET INDICATED BY ALTENS, CLINICAL NIHSS SCORING, fMRI AND BIOMARKERSTimepoint: TO BE ASSESED IN 2 HOURS, 24 HOURS 7 DAYS, 3 WEEKS AND THEN 3 MONTHS - COMPLETE RCT WILL BE FOR 2 YEARS	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDR VINOD KUMAR

DIRECTOR, ADVANCE NEURO AND GENERAL HOSPITAL

drvinodtewari@gmail.com09415022002

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026